[HTML][HTML] Narrative review of drug-associated nail toxicities in oncologic patients
A Emvalomati, V Oflidou, C Papageorgiou… - Dermatology Practical …, 2023 - ncbi.nlm.nih.gov
Objectives We aimed to provide a comprehensive literature review of nail toxicities derived
from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors …
from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors …
[HTML][HTML] Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou, C Papageorgiou… - Dermatology Practical & …, 2023 - dpcj.org
Introduction Nail toxicity represents one of the most common cutaneous adverse effects of
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou, C Papageorgiou… - Dermatology Practical …, 2023 - europepmc.org
Objectives We aimed to provide a comprehensive literature review of nail toxicities derived
from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors …
from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors …
[PDF][PDF] Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou… - Dermatol Pract …, 2023 - pdfs.semanticscholar.org
Nail toxicity represents one of the most common cutaneous adverse effects of both classic
chemotherapeutic agents and new oncologic drugs, including targeted treatments and …
chemotherapeutic agents and new oncologic drugs, including targeted treatments and …
[PDF][PDF] Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou, C Papageorgiou - Dermatol Pract Concept, 2023 - ikee.lib.auth.gr
Nail toxicity represents one of the most common cutaneous adverse effects of both classic
chemotherapeutic agents and new oncologic drugs, including targeted treatments and …
chemotherapeutic agents and new oncologic drugs, including targeted treatments and …
Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou… - Dermatology …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Nail toxicity represents one of the most common cutaneous adverse effects of
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
[PDF][PDF] Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou… - Dermatol Pract …, 2023 - researchgate.net
Nail toxicity represents one of the most common cutaneous adverse effects of both classic
chemotherapeutic agents and new oncologic drugs, including targeted treatments and …
chemotherapeutic agents and new oncologic drugs, including targeted treatments and …
[HTML][HTML] Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, V Oflidou, C Papageorgiou… - Dermatology Practical & …, 2023 - dpcj.org
Introduction Nail toxicity represents one of the most common cutaneous adverse effects of
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients
A Emvalomati, E Kalloniati, E Lazaridou… - … Practical & Conceptual, 2023 - ikee.lib.auth.gr
Introduction Nail toxicity represents one of the most common cutaneous adverse effects of
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
both classic chemotherapeutic agents and new oncologic drugs, including targeted …
Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients.
A Emvalomati, V Oflidou, C Papageorgiou… - Dermatology Practical …, 2023 - europepmc.org
Objectives We aimed to provide a comprehensive literature review of nail toxicities derived
from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors …
from conventional chemotherapeutic agents, targeted therapies (EGFR inhibitors …